2025 Partners
Codexis
Expertise Partner
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
Kaneka
Expertise Partner
Kaneka is a technology-driven company providing valuable CDMO services to our global partners for nearly 50 years. As a pioneer in enzyme technology, we have been producing an array of chiral compounds using Biocatalysis Here, we present some examples of enzymatic process development and scale-up for chiral compounds which are key intermediates for our customer’s pharmaceutical development and commercial programs. Kaneka offers seamless and robust customer support, from enzymatic route design to tonnscale production.
Provolut
Expertise Partner
Provolut is a biotechnology company pioneering an AI-driven enzyme engineering platform to revolutionize the production of active pharmaceutical ingredients (APIs), cell therapies, and antibody-enzyme conjugates. By merging computational design with advanced biocatalysis, Provolut develops sustainable, scalable, and cost-efficient alternatives to traditional chemical synthesis. With a focus on accelerating drug development and reducing environmental impact, Provolut partners with leading pharma and biotech innovators to deliver next-generation manufacturing solutions that expand access to transformative medicines worldwide.
Johnson Matthey
Innovation Partner
From early discovery to commercial production, Johnson Matthey provides comprehensive support to help you at every step of your chemical development journey. With advanced technology, a diverse enzyme portfolio, and a flexible business model, JM’s leading biocatalysis solutions accelerate your progress, helping you bring projects to market faster and more efficiently. Our recent product developments include enzymes for aromatic nitro reduction and efficient cofactor recycling.
Pando
Innovation Partner
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical manufacturing and diagnostics industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our AI models to efficiently optimize enzymes across multiple properties, delivering high-performing, industrial-grade enzymes that create and capture new market value.
Scala Biodesign
Innovation Partner
Scala Biodesign develops one-shot enzyme design software that accelerates the development of high-efficiency, high-yield enzymes with minimal experimental time and effort. Scala’s technologies have been validated by over 50 research labs and top pharma companies, demonstrating versatility across enzyme families and applications. Scala’s platform enables biocatalysis teams to rapidly optimize enzyme stability, selectivity, and activity independently by incorporating multiple mutations in a small number of variants through a single design round
Imperagen
Innovation Partner
Imperagen is a rapidly growing, UK based TechBio company on a mission to transform enzyme innovation. Our Digital Enzyme Evolution™ platform combines laboratory robotics with AI-directed enzyme design in a streamlined architecture. The integrated workflow seamlessly designs, builds, and screens targeted enzyme libraries, gathering high quality data through automated cycles. Our goal is to deliver faster, more substantial performance gains in fewer iterations, producing enzymes engineered precisely for their end application, and more rapidly bridging the gap from concept to market-ready.
EXoZymes
Hosting Partner
eXoZymes has developed a biomanufacturing platform that - as a historic first - offers the tools and insights to design, engineer, control and optimize nature’s own natural processes to produce chemical compounds, enabling the company’s partners to upgrade traditional petro-chemical production methods with a new commercially scalable, sustainable, and eco-friendly alternative: exozymes.
Exozymes are advanced enzymes enhanced through AI and bioengineering to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient biochemical extraction with sustainable and scalable biosolutions that transform biomass into essential chemicals, medicines, and biofuels.
Novonesis
Exhibition Partner
At Novonesis, we help you succeed with innovative biocatalysis. Formed from the merger of Novozymes and Chr. Hansen, we bring over 100 years of expertise in enzymes and microorganisms. Our 10,000 experts deliver high-quality, animal- and plant-free enzymes, proteins, and microbes globally. We support pharma in replacing chemicals and solvents to improve processes cost-effectively by use of sustainable alternatives to chemicals for better APIs and intermediates. In collaboration with you, we transform complex chemistry through cutting-edge biocatalytic processes through our partnership with Seqens.
SEQENS
Exhibition Partner
A pioneer in enzyme engineering and biocatalytic process development since 1998, SEQENS Biotechnologies leverages the global manufacturing power of the SEQENS Group to deliver end-to-end solutions. We provide privileged access to off-the-shelf enzymes, 63M+ unique genes, high-throughput screening, and AI-driven design & selection of enzymes, offering our expertise in fermentation and biocatalytic process scale-up to ensure seamless industrialization. We produce high-value active molecules with optimized or natural microorganisms from our library (5,000 including 600 microalgae).